Market Research Logo

Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020

Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020

According to the CDC, cancer is the second leading cause of mortality, causing ~584,881 deaths worldwide in 2013. Early diagnosis is the key to prevent the rising number of cancer-related deaths. The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms such as next-generation sequencing, DNA microarrays, and polymerase chain reaction (PCR). Moreover, the market has seen the advent of hybrid imaging instruments with enhanced accuracy, such as PET/CT and SPECT/CT. These advancements have augmented the growth of the cancer diagnostics market.

The instrument-based cancer diagnostics segment accounted for the largest share of the global the cancer diagnostics market, by technology, while breast cancer accounted for the largest share of the cancer diagnostics applications market, in 2014.
North America accounted for the largest share of the global cancer diagnostics market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the cancer diagnostics market is expected to experience the highest growth rate in the Asian region, with emphasis on India and China. These countries are expected to serve as revenue pockets for companies operating in the cancer diagnostics market.

The global cancer diagnostics market witnesses high competitive intensity as there are several big and many small firms operating in different segments of the market. These companies adopt various strategies (agreements/partnerships/joint ventures/collaborations, new product launches, geographical expansions, and acquisitions) to increase their market shares and establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the cancer diagnostics market. The report analyzes cancer diagnostics by technology, application, and geography

Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the cancer diagnostics market

Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various cancer diagnostic technologies across regions

Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the cancer diagnostics market

Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the cancer diagnostics market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH METHODOLOGY STEPS
      • SECONDARY AND PRIMARY RESEARCH METHODOLOGY
      • KEY DATA FROM SECONDARY SOURCES
      • KEY DATA FROM PRIMARY SOURCES
      • KEY INSIGHTS FROM PRIMARY SOURCES
      • MARKET SIZE ESTIMATION METHODOLOGY
      • RESEARCH DESIGN
      • MARKET DATA VALIDATION AND TRIANGULATION
      • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
    • INTRODUCTION
    • CURRENT SCENARIO
    • FUTURE OUTLOOK
    • CONCLUSION
  • PREMIUM INSIGHTS
    • GLOBAL CANCER DIAGNOSTICS MARKET
    • REGIONAL SNAPSHOT OF THE CANCER DIAGNOSTICS MARKET
    • CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY (2015 VS. 2020)
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table RISING PREVALENCE OF CANCER IS DRIVING THE GROWTH OF THE CANCER DIAGNOSTICS MARKET
      • RESTRAINTS
        • Table HIGH CAPITAL INVESTMENT RESTRAINING THE GROWTH OF CANCER DIAGNOSTICS MARKET
      • OPPORTUNITIES
        • Table EMERGING MARKETS PRESENT AN ARRAY OF OPPORTUNITIES FOR THE GROWTH OF THE CANCER DIAGNOSTICS MARKET
      • CHALLENGES
        • Table STRINGENT REGULATORY GUIDELINES ARE A MAJOR CHALLENGE IN THE CANCER DIAGNOSTICS MARKET
  • GLOBAL CANCER DIAGNOSTICS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
      • BREAST CANCER
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR BREAST CANCER, BY REGION, 2013-2020 ($MILLION)
      • LUNG CANCER
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR LUNG CANCER, BY REGION, 2013-2020 ($MILLION)
      • COLORECTAL CANCER
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR COLORECTAL CANCER, BY REGION, 2013-2020 ($MILLION)
      • MELANOMA
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR MELANOMA, BY REGION, 2013-2020 ($MILLION)
      • OTHER CANCERS
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR OTHER CANCERS, BY REGION, 2013-2020 ($MILLION)
  • GLOBAL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
    • PLATFORM-BASED DIAGNOSTICS
      • Table GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • Table CANCER DIAGNOSTICS MARKET SIZE FOR PLATFORM-BASED DIAGNOSTICS, BY REGION, 2013-2020 ($MILLION)
      • POLYMERASE CHAIN REACTION (PCR)
        • Table GLOBAL CANCER DIAGNOSTICS MARKET SIZE FOR PCR, BY REGION, 2013-2020 ($MILLION)
        • Table GLOBAL CANCER DIAGNOSTICS MARKET SIZE FOR PCR, BY APPLICATION, 2013-2020 ($MILLION)
      • IN SITU HYBRIDIZATION (ISH)
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR IN SITU HYBRIDIZATION, BY REGION, 2013-2020 ($MILLION)
        • Table GLOBAL CANCER DIAGNOSTICS MARKET SIZE FOR IN SITU HYBRIDIZATION, BY APPLICATION, 2013-2020 ($MILLION)
      • IMMUNOHISTOCHEMISTRY (IHC)
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2013-2020 ($MILLION)
        • Table GLOBAL CANCER DIAGNOSTICS MARKET SIZE FOR IMMUNOHISTOCHEMISTRY, BY APPLICATION, 2013-2020 ($MILLION)
      • NEXT-GENERATION SEQUENCING (NGS)
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR NGS, BY REGION, 2013-2020 ($MILLION)
        • Table GLOBAL CANCER DIAGNOSTICS MARKET SIZE FOR NGS, BY APPLICATION, 2013-2020 ($MILLION)
      • MICROARRAYS
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY REGION, 2013-2020 ($MILLION)
        • Table GLOBAL CANCER DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY APPLICATION, 2013-2020 ($MILLION)
      • FLOW CYTOMETRY
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR FLOW CYTOMETRY, BY REGION, 2013-2020 ($MILLION)
        • Table GLOBAL CANCER DIAGNOSTICS MARKET SIZE FOR FLOW CYTOMETRY, BY APPLICATION, 2013-2020 ($MILLION)
      • OTHER TECHNOLOGIES
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2013-2020 ($MILLION)
        • Table GLOBAL CANCER DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY APPLICATION, 2013-2020 ($MILLION)
    • INSTRUMENT-BASED
      • Table GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • DIAGNOSTIC IMAGING
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR DIAGNOSTIC IMAGING, BY PRODUCT, 2013-2020 ($MILLION)
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR DIAGNOSTIC IMAGING, BY REGION, 2013-2020 ($MILLION)
        • Table GLOBAL CANCER DIAGNOSTICS MARKET SIZE FOR IMAGING, BY APPLICATION, 2013-2020 ($MILLION)
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR MRI, BY REGION, 2013-2020 ($MILLION)
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR CT, BY REGION, 2013-2020 ($MILLION)
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR PET, BY PRODUCT, 2013-2020 ($MILLION)
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR PET, BY REGION, 2013-2020 ($MILLION)
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR STANDALONE PET, BY REGION, 2013-2020 ($MILLION)
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR HYBRID PET, BY REGION, 2013-2020 ($MILLION)
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR MAMMOGRAPHY, BY REGION, 2013-2020 ($MILLION)
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR ULTRASOUND, BY REGION, 2013-2020 ($MILLION)
      • BIOPSIES
        • Table CANCER DIAGNOSTICS MARKET SIZE FOR BIOPSY, BY REGION, 2013-2020 ($MILLION)
        • Table GLOBAL CANCER DIAGNOSTICS MARKET SIZE FOR BIOPSY, BY APPLICATION, 2013-2020 ($MILLION)
  • CANCER DIAGNOSTICS MARKET, BY REGION
    • INTRODUCTION
    • NORTH AMERICA
      • Table NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2013-2020 ($MILLION)
      • Table NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • Table NORTH AMERICA: CANCER DIAGNOSTICS PLATFORM-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • Table NORTH AMERICA: CANCER DIAGNOSTICS INSTRUMENT-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • Table NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2013-2020 ($MILLION)
      • U.S.
        • Table U.S.: CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table U.S.: CANCER DIAGNOSTICS PLATFORM-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table U.S.: CANCER DIAGNOSTICS INSTRUMENT-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • CANADA
        • Table CANADA: CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table CANADA: CANCER DIAGNOSTICS PLATFORM-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table CANADA: CANCER DIAGNOSTICS INSTRUMENT-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
    • EUROPE
      • Table EUROPE: CANCER DIAGNOSTICS MARKET, BY REGION, 2013-2020 ($MILLION)
      • FUNDING FOR CANCER DIAGNOSTICS RESEARCH
        • Table EUROPE: CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table EUROPE: CANCER DIAGNOSTICS PLATFORM-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table EUROPE: CANCER DIAGNOSTICS INSTRUMENT MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table EUROPE: CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2013-2020 ($MILLION)
      • EU-5 (U.K., GERMANY, FRANCE, ITALY, SPAIN)
        • Table EU-5: CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table EU-5: CANCER DIAGNOSTICS PLATFORM-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table EU-5: CANCER DIAGNOSTICS INSTRUMENT-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • REST OF EUROPE (ROE)
        • Table ROE: CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table ROE: CANCER DIAGNOSTICS PLATFORM-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table ROE: CANCER DIAGNOSTICS INSTRUMENT-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
    • ASIA
      • Table ASIA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2013-2020 ($MILLION)
      • Table ASIA: CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • Table ASIA: CANCER DIAGNOSTICS PLATFORM-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • Table ASIA: CANCER DIAGNOSTICS INSTRUMENT-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • Table ASIA: CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2013-2020 ($MILLION)
      • CHINA
        • Table CHINA: CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table CHINA: CANCER DIAGNOSTICS PLATFORM-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table CHINA: CANCER DIAGNOSTICS INSTRUMENT-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • JAPAN
        • Table JAPAN: CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table JAPAN: CANCER DIAGNOSTICS PLATFORM-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table JAPAN: CANCER DIAGNOSTICS INSTRUMENT-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • INDIA
        • Table INDIA: CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table INDIA: CANCER DIAGNOSTICS PLATFORM-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table INDIA: CANCER DIAGNOSTICS INSTRUMENT-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • REST OF ASIA
        • Table ROA: CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table ROA: CANCER DIAGNOSTICS PLATFORM-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table ROA: CANCER DIAGNOSTICS INSTRUMENT-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
    • REST OF THE WORLD (ROW)
      • GOVERNMENT INITIATIVES BOOSTING DEMAND FOR CANCER DIAGNOSTICS
      • AGING POPULATION, PRESENCE OF INTERNATIONAL PLAYERS
      • INCREASE IN CANCER INCIDENCES AND RISING GOVERNMENT EXPENDITURE
      • GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE
        • Table ROW: CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table ROW: CANCER DIAGNOSTICS PLATFORM-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table ROW: CANCER DIAGNOSTICS INSTRUMENT-BASED MARKET, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table ROW: CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2013-2020 ($MILLION)
  • COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPETITIVE LANDSCAPE: OVERVIEW
    • COMPETITIVE SITUATION AND TRENDS
      • COLLABORATIONS/AGREEMENTS/PARTNERSHIPS/ALLIANCES
        • Table COLLABORATIONS/AGREEMENTS/PARTNERSHIPS/ALLIANCES, 2012-2015
      • NEW PRODUCT LAUNCHES
        • Table NEW PRODUCT LAUNCHES, 2012-2015
      • ACQUISITIONS
        • Table ACQUISITIONS, 2012-2015
      • EXPANSION
        • Table EXPANSIONS, 2012-2015
      • OTHERS
        • Table OTHER STRATEGIES, 2012-2015
  • COMPANY PROFILES
    • INTRODUCTION
    • QIAGEN N.V.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • BECTON, DICKINSON AND COMPANY
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • ABBOTT LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • ROCHE HOLDING AG
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • THERMO FISHER SCIENTIFIC, INC.
      • BUSINESS OVERVIEW
      • THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • AGILENT TECHNOLOGIES, INC.
      • BUSINESS OVERVIEW
      • AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • ILLUMINA, INC.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • SIEMENS HEALTHCARE
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • C.R. BARD, INC.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
  • APPENDIX
    • DISCUSSION GUIDE
    • COMPANY DEVELOPMENTS (2012-2015)
      • QIAGEN N.V.
      • BECTON, DICKINSON AND COMPANY
      • GE HEALTHCARE
      • ABBOTT LABORATORIES
      • ROCHE HOLDING AG
      • THERMO FISHER SCIENTIFIC, INC.
      • AGILENT TECHNOLOGIES, INC.
      • ILLUMINA, INC.
      • SIEMENS HEALTHCARE
    • AVAILABLE CUSTOMIZATIONS
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report